Two new donor–acceptor (D–A) type copolymers, poly{5,11-di(1-decylundecyl)indolo[3,2-b]carbazole-3,9-diyl-alt-4,7-dithien-2-yl-2,1,3-benzothiadiazole-5′,5″-diyl} (PIC-DTBT) and poly{5,11-di(1-decylundecyl)indolo[3,2-b]carbazole-3,9-diyl-alt-4,7-di(2,2′-bithien-5-yl)-2,1,3-benzothiadiazole-5′,5″-diyl} (PIC-DT2BT) were synthesized. The polymers have an alternating structure consisting of a large-size fused aromatic ring, indolo[3,2-b]carbazole (IC), as the donor segment and 4,7-dithien-2-yl-2,1,3-benzothiadiazole (DTBT) or 4,7-di(2,2′-bithien-5-yl)-2,1,3-benzothiadiazole (DT2BT) as the acceptor segment. The absorption spectra and the electrochemical properties of PIC-DTBT and PIC-DT2BT indicate that these copolymers have suitable energy levels for photovoltaic application. Polymer photovoltaic devices based on blends of the copolymers and [6,6]-phenyl C61 butyric acid methyl ester (PCBM) have a high open-circuit voltage (>0.9 V) under the illumination of AM 1.5 (100 mW cm−2). The higher power conversion efficiency (PCE) of PIC-DT2BT (2.07%) compared to that of PIC-DTBT (1.47%) suggests that DT2BT could be a promising building block for the efficient D–A type copolymers if the low solubility is overcome by the molecular design of the donor segment.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: